India has taken several steps to remove animals from the drug-testing process. Here are some of the key initiatives:

• The Indian Pharmacopoeia Commission (IPC) has established guidelines and regulatory requirements to reduce and eventually eliminate animal testing for drug development.
• India has implemented the Integrated Non-animal Toxicity Testing Approach (INATT), which promotes the use of alternative testing methods such as in vitro models, computer simulations, and human clinical data.
• The Indian Council of Medical Research (ICMR) has set up the National Centre for Laboratory Animal Sciences (NCLAS) to educate researchers on alternative testing methods and to provide validation and accreditation services for non-animal testing techniques.
• Government organizations and research institutions are encouraged to adopt the 3R principle: Replace, Reduce, and Refine. This principle promotes the use of alternate methods, minimizes the number of animals used in experiments, and improves the welfare of animals involved in testing.
• India has actively participated in international collaborations and conferences to share knowledge and best practices in implementing alternative testing methods and exchanging information on non-animal research techniques.
• Various organizations in the country are conducting research on developing new methods for toxicity testing that rely less on animal models, such as organs-on-chips, microfluidics, and computer modeling.

These steps reflect India's commitment to reducing and eventually eliminating the use of animals in drug-testing processes, promoting human-relevant and ethical approaches to pharmaceutical research.